Mechanisms of Human Insulin Resistance
Mechanisms of Human Insulin Resistance
批准号:
8001364
负责人:
W Timothy GARVEY
金额:
$7.41万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-31 至 2011-03-31
关键词:
2,4-thiazolidinedioneAffectBiogenesisBody CompositionBody WeightBody Weight decreasedBody fatCarbohydratesCardiovascular DiseasesComplexCouplingDataDefectDietExhibitsFatty acid glycerol estersGene ExpressionGenerationsGenesGlucoseGrantHealth Care CostsHumanIndirect CalorimetryIndividualInjuryInsulinInsulin ResistanceLipidsMass Spectrum AnalysisMeasuresMessenger RNAMetabolicMetabolic syndromeMetabolismMethodsMitochondriaMitochondrial ProteinsModificationMolecularMorphologyMuscleMuscle MitochondriaNADH dehydrogenase (ubiquinone)Non-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsNuclearObesityPathogenesisPatientsPhysiologyPost-Translational Protein ProcessingProductionProteinsProteomeProteomicsProtonsRegulationResearch DesignResistanceResolutionRespiratory ChainSkeletal MuscleSpectrum AnalysisStaining methodStainsStructureTestingThiazolidinedionesTimeTissue-Specific Gene ExpressionToxic effectTwo-Dimensional Gel ElectrophoresisZucker RatsbasecDNA Arrayscomplex IVdensityfeedinggel electrophoresisglucose uptakeinsulin sensitivityinsulin sensitizing drugsmRNA Expressionmitochondrial dysfunctionmitochondrial genomeoil red Ooxidationprotein complexprotein expressionresearch studyrespiratoryrespiratory protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Insulin resistance is central to the pathogenesis of Type 2 diabetes (T2DM), the Metabolic Syndrome, and cardiovascular disease, and presents a heavy burden of patient suffering and health care costs. The immediate cause involves defective stimulation of glucose uptake into skeletal muscle. Insulin resistance is also associated with abnormalities in fat oxidation and accumulation of intramyocellular lipid (IMCL), although molecular mechanisms are unknown. Since mitochondria are responsible for lipid oxidation, it is tempting to explain increased IMCL on the basis of mitochondrial dysfunction, and there is recent evidence to support this idea. Over the past grant cycle, we have examined differential gene expression in human muscle using cDNA microarrays and found that multiple genes encoding mitochondrial proteins are down-regulated in insulin resistance. This data, together with the observation that insulin resistance involves selective depletion of complex IV proteins, have led us to a more detailed examination of the mitochondrial proteome and function in skeletal muscle. The current proposal combines human physiology and basic methods to test the hypotheses that: 1) specific depletion of respiratory complex proteins per mitochondrion and a decrease in mitochondrial mass impair substrate oxidation and promote IMCL accumulation in insulin resistance and T2DM; 2) these abnormalities increase ROS production which further compromises function in association with oxidative protein modifications, particularly in uncontrolled T2DM. To test these hypotheses, we will study metabolically-characterized insulin sensitive and resistant normoglycemic subjects over a range of body weight, and T2DM patients both in the untreated state and after euglycemic therapy to reverse the "glucose toxicity" component of insulin resistance. Perturbation studies will be performed before and after an insulin-sensitizing thiazolidinedione, and hypocaloric feeding & weight loss, in order to probe relationships with muscle mitochrondrial mass and morphology, and to study respiratory chain proteomics using 2D blue native gel electrophoresis and mass spectrometry. To assess mitochondrial function, we will measure carbohydrate and lipid substrate oxidation by high resolution respirotometry, activity of individual respiratory chain complexes I-IV, coupling status, ROS/RNS generation, and post-translational oxidative modifications affecting mitochondrial proteins. We will also examine whether discordant regulation between nuclear and mitochondrial genomes could underlie mitochondrial dysfunction. These studies will for the first time delineate functional and molecular defects in muscle mitochondria related to defects in substrate oxidation and IMCL in human insulin resistance.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes. Chronic ability to increase glycogen synthase activity.
原代培养的脂肪细胞中葡萄糖和胰岛素对胰岛素的生物学作用有不同的调节。
DOI:
10.2337/diab.43.1.53
发表时间:
1994
期刊:
Diabetes
影响因子:
7.7
作者:
[Lima,FB, Bao,S, Garvey,WT]
通讯作者:
Garvey,WT
DOI:
10.1002/oby.21344
发表时间:
2016-02
期刊:
Obesity (Silver Spring, Md.)
影响因子:
--
作者:
[Guo F, Garvey WT]
通讯作者:
Garvey WT
Potential role for insulin and cycloheximide in regulating the intrinsic activity of glucose transporters in isolated rat adipocytes.
胰岛素和放线菌酮在调节离体大鼠脂肪细胞葡萄糖转运蛋白内在活性中的潜在作用。
DOI:
10.1210/endo.133.6.8243322
发表时间:
1993
期刊:
Endocrinology
影响因子:
4.8
作者:
[Karnieli,E, Garvey,WT, Olefsky,JM, Hueckstead,TP, Harel,C, Maianu,L, Armoni,M]
通讯作者:
Armoni,M
Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition.
肌肉 Rad 表达和人体代谢:新型 Ras 相关 GTP 酶在能量消耗和身体成分中的潜在作用。
DOI:
10.2337/diab.46.3.444
发表时间:
1997
期刊:
Diabetes
影响因子:
7.7
作者:
[Garvey,WT, Maianu,L, Kennedy,A, Wallace,P, Ganaway,E, Hamacher,LL, Yarnall,DP, Lenhard,JM, Burns,DK]
通讯作者:
Burns,DK
DOI:
10.1371/journal.pone.0150943
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Zhang W, Hartmann R, Tun HM, Elson CO, Khafipour E, Garvey WT]
通讯作者:
Garvey WT
共 27 条
Depletion of pancreatic lipid improves beta-cell function in early type 2 diabetes
-
批准号:9902431
-
项目类别:
-
资助金额:$53.28万
-
财政年份:2018
-
负责人:W Timothy GARVEY
-
依托单位:
Depletion of pancreatic lipid improves beta-cell function in early type 2 diabetes
-
批准号:10379925
-
项目类别:
-
资助金额:$53.28万
-
财政年份:2018
-
负责人:W Timothy GARVEY
-
依托单位:
Mechanisms of Insulin Resistance in Diabetes
-
批准号:9124595
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8250814
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8391095
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Mechanisms of Insulin Resistance in Diabetes
-
批准号:8922734
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8048752
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
Pathogenesis of the Metabolic Syndrome
-
批准号:8586874
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:7741945
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:8116981
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:8310114
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
NR4A Orphan Receptors And Insulin Resistance
-
批准号:7904944
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2009
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:9012079
-
项目类别:
-
资助金额:$114.31万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:9975810
-
项目类别:
-
资助金额:$124.51万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
University of Alabama at Birmingham's Diabetes Research Center
-
批准号:10183228
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:10855174
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research and Training Center
-
批准号:8061668
-
项目类别:
-
资助金额:$148.96万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:8897347
-
项目类别:
-
资助金额:$114.34万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research and Training Center
-
批准号:7336870
-
项目类别:
-
资助金额:$167.58万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
UAB Diabetes Research Center
-
批准号:8436584
-
项目类别:
-
资助金额:$113.34万
-
财政年份:2008
-
负责人:W Timothy GARVEY
-
依托单位:
海外基金